Phase 0 1 trial
Phase 0
NCT04890236 Jan 2022 → Mar 2024 diffuse large B-cell lymphoma Emory University
Completed
No outcome recorded
Phase 1 20 trials
Phase 1
NCT07714187 Jan 2027 → Oct 2028 expected mycosis fungoides SecuraBio
Not yet recruiting
No outcome recorded
Phase 1
NCT07001384 Aug 2025 → Aug 2031 expected ALK-positive anaplastic large cell lymphoma Memorial Sloan Kettering Cancer Center
Recruiting
No outcome recorded
Phase 1
NCT04639843 Nov 2022 adult T-cell leukemia/lymphoma , enteropathy-associated T-cell lymphoma , extranodal nasal NK/T cell lymphoma , hepatosplenic T-cell lymphoma +1 National Cancer Institute (NCI)
Withdrawn
No outcome recorded
Phase 1
NCT04836832 Jul 2022 → Dec 2023 follicular lymphoma , nodal marginal zone B-cell lymphoma , splenic marginal zone lymphoma Narendranath Epperla
Withdrawn
No outcome recorded
Phase 1
NCT05044039 Feb 2022 → Jan 2026 overdue acute lymphoblastic leukemia Washington University School of Medicine
Active not recruiting
No outcome recorded
Phase 1
NCT05065866 Nov 2021 → Jan 2024 Hodgkins lymphoma , lymphoid leukemia , non-Hodgkin lymphoma , plasma cell myeloma H. Lee Moffitt Cancer Center and Research Institute
Completed
No outcome recorded
Phase 1
NCT04652960 Oct 2021 → Dec 2026 expected primary cutaneous T-cell lymphoma National Cancer Institute (NCI)
Active not recruiting
No outcome recorded
Phase 1
NCT05010005 Aug 2021 → Aug 2027 expected T-cell large granular lymphocyte leukemia , T-cell prolymphocytic leukemia Memorial Sloan Kettering Cancer Center
Recruiting
No outcome recorded
Phase 1
NCT03892044 Nov 2019 → Feb 2024 Richter transformation , chronic lymphocytic leukemia/small lymphocytic lymphoma , diffuse large B-cell lymphoma David Bond, MD
Completed
No outcome recorded
Phase 1
NCT02640833 Jul 2016 → Jan 2020 chronic lymphocytic leukemia/small lymphocytic lymphoma AbbVie
Withdrawn
No outcome recorded
Phase 1
NCT02783625 May 2016 → Apr 2026 T-cell non-Hodgkin lymphoma Memorial Sloan Kettering Cancer Center
Completed
No outcome recorded
Phase 1
NCT02598570 Nov 2015 → Dec 2016 lymphoma AbbVie
Completed
No outcome recorded
Phase 1
NCT02292225 Feb 2015 → Nov 2016 chronic lymphocytic leukemia/small lymphocytic lymphoma SecuraBio
Terminated
No outcome recorded
Phase 1
NCT02095587 Mar → Jul 2014 —
SecuraBio
Completed
No outcome recorded
Phase 1
NCT01947777 Oct → Nov 2013 —
SecuraBio
Completed
No outcome recorded
Phase 1
NCT01925911 Aug → Sep 2013 —
SecuraBio
Completed
No outcome recorded
Phase 1
NCT01871675 May 2013 → Jun 2016 T-cell non-Hodgkin lymphoma , chronic lymphocytic leukemia/small lymphocytic lymphoma SCRI Development Innovations, LLC
Completed
No outcome recorded
Phase 1
NCT01836861 Mar → Apr 2013 —
SecuraBio
Completed
No outcome recorded
Phase 1
NCT01476657 Oct 2011 → Dec 2016 hematopoietic and lymphoid cell neoplasm SecuraBio
Terminated
No outcome recorded
Phase 1
NCT01549106 Aug 2011 → Feb 2012 —
SecuraBio
Completed
No outcome recorded
Show 10 more trials Phase 1/2 8 trials
Phase 1/2
NCT06810778 May 2025 → Jun 2030 expected T-cell prolymphocytic leukemia , primary cutaneous T-cell lymphoma Jonsson Comprehensive Cancer Center
Recruiting
No outcome recorded
Phase 1/2
NCT05675813 Feb 2023 → Jul 2026 overdue peripheral T-cell lymphoma, not otherwise specified Ruijin Hospital
Recruiting
No outcome recorded
Phase 1/2
NCT05508659 Sep 2022 → Sep 2024 cancer CSPC ZhongQi Pharmaceutical Technology Co., Ltd.
Unknown
No outcome recorded
Phase 1/2
NCT04688658 Oct 2021 → Feb 2024 melanoma John Kirkwood
Terminated
No outcome recorded
Phase 1/2
NCT04193293 Jun → Dec 2020 head and neck squamous cell carcinoma SecuraBio
Terminated
No outcome recorded
Phase 1/2
NCT03534323 Jul 2018 → Dec 2024 overdue B-cell chronic lymphocytic leukemia , Richter transformation Dana-Farber Cancer Institute
Active not recruiting
No outcome recorded
Phase 1/2
NCT02391545 Dec 2014 → Jan 2017 follicular lymphoma SecuraBio
Terminated
No outcome recorded
Phase 1/2
NCT02158091 Jun 2014 → Oct 2017 overdue B-cell chronic lymphocytic leukemia Dana-Farber Cancer Institute
Active not recruiting
No outcome recorded
Phase 2 19 trials
Phase 2
NCT07293403 Jun 2026 → Nov 2027 expected Nodal T-follicular helper cell lymphoma, follicular type , peripheral T-cell lymphoma, not otherwise specified City of Hope Medical Center
Recruiting
No outcome recorded
Phase 2
NCT06530550 Aug 2024 → Aug 2026 overdue T-cell large granular lymphocyte leukemia , chronic lymphoproliferative disorder of NK-cells Institute of Hematology & Blood Diseases Hospital, China
Recruiting
No outcome recorded
Phase 2
NCT05976997 May 2023 → Oct 2026 expected peripheral T-cell lymphoma, not otherwise specified Liling Zhang
Recruiting
No outcome recorded
Phase 2
NCT05057247 Oct 2021 → Oct 2023 head and neck squamous cell carcinoma Glenn J. Hanna
Completed
No outcome recorded
Phase 2
NCT04803201 Oct 2021 → May 2027 Nodal T-follicular helper cell lymphoma, follicular type , angioimmunoblastic T-cell lymphoma , enteropathy-associated T-cell lymphoma , monomorphic epitheliotropic intestinal T-cell lymphoma +1 Alliance for Clinical Trials in Oncology
Suspended
No outcome recorded
Phase 2
NCT04487886 Nov 2020 → Jun 2021 COVID-19 Emory University
Completed
No outcome recorded
Phase 2
NCT04372602 Oct 2020 → Feb 2022 COVID-19 Washington University School of Medicine
Completed
No outcome recorded
Phase 2
NCT04209621 Jul 2020 → Jan 2021 chronic lymphocytic leukemia/small lymphocytic lymphoma National Heart, Lung, and Blood Institute (NHLBI)
Terminated
No outcome recorded
Phase 2
NCT04331119 Jul 2020 → Apr 2026 T-cell non-Hodgkin lymphoma Washington University School of Medicine
Terminated
No outcome recorded
Phase 2
NCT03961672 May 2020 → Jul 2023 overdue chronic lymphocytic leukemia/small lymphocytic lymphoma City of Hope Medical Center
Active not recruiting
No outcome recorded
Phase 2
NCT04707079 Dec 2019 → Oct 2021 follicular lymphoma CSPC ZhongQi Pharmaceutical Technology Co., Ltd.
Unknown
No outcome recorded
Phase 2
NCT04038359 Sep 2019 → Jul 2023 indolent B-cell non-Hodgkin lymphoma SecuraBio
Completed
No outcome recorded
Phase 2
NCT03372057 Feb 2018 → Dec 2023 peripheral T-cell lymphoma, not otherwise specified SecuraBio
Completed
No outcome recorded
Phase 2
NCT03370185 Feb 2018 → Jun 2020 chronic lymphocytic leukemia/small lymphocytic lymphoma SecuraBio
Withdrawn
No outcome recorded
Phase 2
NCT02711852 Apr 2016 → May 2020 hematopoietic and lymphoid cell neoplasm SecuraBio
Completed
No outcome recorded
Phase 2
NCT02605694 Dec 2015 → Nov 2016 lymphoma SecuraBio
Withdrawn
No outcome recorded
Phase 2
NCT02028039 Dec 2013 → Dec 2016 leukemia M.D. Anderson Cancer Center
Withdrawn
No outcome recorded
Phase 2
NCT01882803 Jun 2013 → Nov 2020 indolent B-cell non-Hodgkin lymphoma SecuraBio
Completed
No outcome recorded
Phase 2
NCT01851707 Apr 2013 → Dec 2014 rheumatoid arthritis SecuraBio
Completed
No outcome recorded
Show 9 more trials Phase 3 5 trials
Phase 3
NCT06522737 May 2025 → Feb 2028 expected lymphoma SecuraBio
Recruiting
No outcome recorded
Phase 3
NCT02576275 Dec 2015 → Nov 2016 chronic lymphocytic leukemia/small lymphocytic lymphoma , follicular lymphoma , marginal zone lymphoma SecuraBio
Withdrawn
No outcome recorded
Phase 3
NCT02204982 Sep 2014 → Dec 2016 follicular lymphoma SecuraBio
Terminated
No outcome recorded
Phase 3
NCT02049515 Dec 2013 → Jun 2020 chronic lymphocytic leukemia/small lymphocytic lymphoma SecuraBio
Completed
No outcome recorded
Phase 3
NCT02004522 Nov 2013 → May 2017 chronic lymphocytic leukemia/small lymphocytic lymphoma SecuraBio
Completed
No outcome recorded